ELAVL1 Antikörper
Kurzübersicht für ELAVL1 Antikörper (ABIN2720122)
Target
Alle ELAVL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human ELAVL1(NP_001410) produced in HEK293T cell.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB 1:1000, IHC 1:50,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
-
: "Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells." in: Cancer letters, Vol. 382, Issue 1, pp. 21-31, (2016) (PubMed).
-
-
- ELAVL1 (ELAV (Embryonic Lethal, Abnormal Vision, Drosophila)-Like 1 (Hu Antigen R) (ELAVL1))
-
Andere Bezeichnung
- ELAVL1
-
Molekulargewicht
- 36.1 kDa
-
Gen-ID
- 1994
-
NCBI Accession
- NM_001419
-
HGNC
- 751
-
Pathways
- AMPK Signaling
Target
-